Eli Lilly CEO Reiterates 5% Revenue Growth Target

Dave Ricks, chief executive officer at Eli Lily & Co., talks about a regulatory roadblock for a rheumatoid arthritis drug and potential risks to the company’s revenue growth commitment. He speaks with Bloomberg's David Westin on "Bloomberg Daybreak: Americas." (Source: Bloomberg)

Full Show: Bloomberg Businessweek (09/22)
31:58 - Bloomberg Television takes you behind the scenes of our award-winning magazine "Bloomberg Businessweek." Hosts Carol Massar and Julia Chatterley talk with the writers who break news on a weekly basis and get a lighter touch from the editor who oversees the Etc. section. (Source: Bloomberg)
  • Who Moved the Most on Bloomberg's Billionaire Index 9/22
  • Full Show: Bloomberg Best (09/22)
  • Panama Min. Says Anonymous Corporations Are in the Past